NCT00852202 - Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression | Biotech Hunter

Enrollment

234

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 15, 2010

Study Completion Date

June 15, 2010

Conditions

Bipolar Depression

Interventions

DRUG

cariprazine

Drug: cariprazine (0.25 - 0.75 mg/day)

DRUG

cariprazine

Drug: cariprazine (1.5 - 3.0 mg/day)

DRUG

placebo

placebo capsules, oral administration, once daily dosing

Trial Locations (26)

10467

Forest Investigative Site 001, The Bronx

19063

Forest Investigative Site 006, Media

19107

Forest Investigative Site 011, Philadelphia

21061

Forest Investigative Site 024, Glen Burnie

27710

Forest Investigative Site 018, Durham

32216

Forest Investigative Site 007, Jacksonville

32806

Forest Investigative Site 026, Orlando

33407

Forest Investigative Site 012, West Palm Beach

34208

Forest Investigative Site 020, Bradenton

34741

Forest Investigative Site 019, Kissimmee

37212

Forest Investigative Site 014, Nashville

45040

Forest Investigative Site 022, Mason

45417

Forest Investigative Site 004, Dayton

63141

Forest Investigative Site 029, Creve Coeur

68131

Forest Investigative Site 002, Omaha

75062

Forest Investigative Site 023, Irving

91316

Forest Investigative Site 005, Encino

91950

Forest Investigative Site 027, National City

92056

Forest Investigative Site 010, Oceanside

92660

Forest Investigative Site 013, Newport Beach

92845

Forest Investigative Site 017, Garden Grove

97210

Forest Investigative Site 015, Portland

98004

Forest Investigative Site 009, Bellevue

98104

Forest Investigative Site 016, Seattle

08002

Forest Investigative Site 028, Cherry Hill

05091

Forest Investigative Site 003, Woodstock